The effect of vitamin C in the treatment of patients with COVID-19
Phase 2
Recruiting
- Conditions
- COVID-19 patients.COVID-19, virus identifiedU07.1
- Registration Number
- IRCT20210714051891N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Respiratory failure index (RIF)
Treated in the IC
Exclusion Criteria
Patients with a history of vitamin C allergy.
Patients with asthma due to cardiopulmonary edema
Pregnant or lactating women
Patients with a survival time of less than 24 hours
Patients with a history of end-stage lung disease, end-stage malignant tumor, G-6-PD deficiency, diabetic ketoacidosis, active kidney stone disease, and severe kidney disease
Patients who have already enrolled in another clinical trial
Patients with a known history of kidney disease, chronic renal failure, or acute renal failure during hospitalization
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method